Financhill
Sell
48

RYTM Quote, Financials, Valuation and Earnings

Last price:
$59.60
Seasonality move :
-17.84%
Day range:
$56.54 - $60.52
52-week range:
$35.17 - $68.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
32.24x
P/B ratio:
329.18x
Volume:
864.7K
Avg. volume:
534.3K
1-year change:
33.1%
Market cap:
$3.7B
Revenue:
$77.4M
EPS (TTM):
-$4.33

Earnings Data

Next earnings date for RYTM
Feb 21
2025
Most recent earnings per share
-$0.73
Beat by $0.14
(Nov 5/2024)
Consensus Estimate
-$0.87
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RYTM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $38.4M -- -- -$0.73 --
02/21/2025 Q4 $36.1M -- -- -$0.77 --
11/05/2024 Q3 $32.5M $33.3M -$0.73 -$0.87 $0.14
08/06/2024 Q2 $28.8M $29.1M -$0.55 -$0.72 $0.17
05/07/2024 Q1 $26.9M $26M -$2.35 -$2.39 $0.04
02/22/2024 Q4 $25.4M $24.2M -$0.70 -$0.71 $0.01
11/07/2023 Q3 -- -- -$0.76 -$0.76 -$0.00
08/01/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/02/2023 Q1 -- -- -$0.92 -$0.77 -$0.15
03/01/2023 Q4 -- -- -$0.75 -$0.78 $0.03
11/08/2022 Q3 -- -- -$0.79 -$0.98 $0.19
08/02/2022 Q2 -- -- -$0.89 -$1.03 $0.14
05/03/2022 Q1 -- -- -$1.05 -$1.04 -$0.01
03/01/2022 Q4 -- -- -$0.85 -$0.93 $0.08
11/02/2021 Q3 -- -- -$0.70 -$0.83 $0.13
08/03/2021 Q2 -- -- -$0.70 -$0.74 $0.04
05/03/2021 Q1 -- -- $0.90 -$0.70 $1.60
03/01/2021 Q4 -- -- -$0.79 -$0.79 --
11/02/2020 Q3 -- -- -$0.77 -$0.80 $0.03
08/03/2020 Q2 -- -- -$0.71 -$0.82 $0.11
05/04/2020 Q1 -- -- -$0.78 -$0.82 $0.04
03/02/2020 Q4 -- -- -$0.78 -$0.92 $0.14
11/01/2019 Q3 -- -- -$1.04 -$1.10 $0.06
07/29/2019 Q2 -- -- -$1.24 -$0.85 -$0.39
05/03/2019 Q1 -- -- -$0.84 -$0.73 -$0.11
03/08/2019 Q4 -- -- -$0.74 -$0.66 -$0.08
11/09/2018 Q3 -- -- -$0.52 -$0.61 $0.09
08/08/2018 Q2 -- -- -$0.52 -$0.47 -$0.05
05/14/2018 Q1 -- -- -$0.60 -- --
03/12/2018 Q4 -- -- -$0.41 -$0.55 $0.14
11/14/2017 Q3 -- -- -$0.66 -$0.56 -$0.11

Rhythm Pharmaceuticals Earnings Questions

  • How Much did Rhythm Pharmaceuticals Generate in Revenue Last Quarter?

    Rhythm Pharmaceuticals reported $33.3M worth of top line sales in its most recent quarter.

  • Did Rhythm Pharmaceuticals Beat Earnings Last Quarter?

    Rhythm Pharmaceuticals announced earnings per share of -$0.73 which represents a beat of analyst forecast a -$0.87 per share.

  • Is Rhythm Pharmaceuticals Profitable?

    Rhythm Pharmaceuticals reported $29.4M that represents $0.48 per share over the last quarter.

  • What is the Analyst Consensus for Rhythm Pharmaceuticals EPS Next Year?

    Rhythm Pharmaceuticals's earnings are forecast to decrease from -$3.20 per share to -$4.13 per share next year representing a decrease of -37.93%.

  • When is Rhythm Pharmaceuticals's Earnings Date?

    Rhythm Pharmaceuticals's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Carlos Slim Buy PBF Energy?
Why Did Carlos Slim Buy PBF Energy?

Carlos Slim made a splash in a surprising sector last…

Is Booking Holdings Stock Undervalued?
Is Booking Holdings Stock Undervalued?

There is a lot of humdrum in the market about…

Broadcom vs American Express: Which Is Best?
Broadcom vs American Express: Which Is Best?

Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
47
DRUG alert for Jan 3

Bright Minds Biosciences [DRUG] is down 4.28% over the past day.

Buy
88
BMA alert for Jan 3

Banco Macro SA [BMA] is up 0.88% over the past day.

Sell
50
AGFY alert for Jan 3

Agrify [AGFY] is down 5.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock